Lack of c-kit (CD117) expression in CD30+ lymphomas and lymphomatoid papulosis

George Z. Rassidakis(The University of Texas MD Anderson Cancer Center), L. Jeffrey Medeiros(The University of Texas MD Anderson Cancer Center)

Modern Pathology

April 23, 2004

10.1038/modpathol.3800144

Cited by 24

Related Papers

Activation of Mammalian Target of Rapamycin Signaling Promotes Cell Cycle Progression and Protects Cells from Apoptosis in Mantle Cell Lymphoma

|American Journal Of Pathology|2006|118

mTOR signaling is activated by FLT3 kinase and promotes survival of FLT3- mutated acute myeloid leukemia cells

|Molecular Cancer|2010|105

NPM-ALK oncogenic kinase promotes cell-cycle progression through activation of JNK/cJun signaling in anaplastic large-cell lymphoma

|Blood|2007|83

Activation of the p53 pathway by the MDM2 inhibitor nutlin-3a overcomes BCL2 overexpression in a preclinical model of diffuse large B-cell lymphoma associated with t(14;18)(q32;q21)

|Leukemia|2011|66

mTOR downstream effectors, 4EBP1 and eIF4E, are overexpressed and associated with HPV status in precancerous lesions and carcinomas of the uterine cervix

|Oncology Letters|2016|17